Concepts (152)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hospitals, Pediatric | 9 | 2020 | 1860 | 1.330 |
Why?
|
Respiratory Therapy | 3 | 2020 | 125 | 0.990 |
Why?
|
Disabled Children | 2 | 2016 | 251 | 0.900 |
Why?
|
Rehabilitation Centers | 3 | 2015 | 246 | 0.900 |
Why?
|
Rehabilitation | 2 | 2015 | 130 | 0.860 |
Why?
|
Oxygen Inhalation Therapy | 6 | 2024 | 411 | 0.850 |
Why?
|
Disability Evaluation | 3 | 2016 | 1836 | 0.850 |
Why?
|
Ventilator Weaning | 3 | 2007 | 164 | 0.710 |
Why?
|
Subacute Care | 2 | 2020 | 179 | 0.630 |
Why?
|
Respiration, Artificial | 5 | 2015 | 2630 | 0.560 |
Why?
|
Infant, Premature | 4 | 2024 | 2107 | 0.550 |
Why?
|
Hospitals, Chronic Disease | 1 | 2014 | 9 | 0.480 |
Why?
|
Hospital Units | 1 | 2015 | 142 | 0.470 |
Why?
|
Respiratory Insufficiency | 4 | 2007 | 1230 | 0.450 |
Why?
|
Patient Readmission | 5 | 2017 | 3271 | 0.440 |
Why?
|
Neonatal Abstinence Syndrome | 1 | 2015 | 108 | 0.430 |
Why?
|
Patient Discharge | 5 | 2017 | 3443 | 0.430 |
Why?
|
Length of Stay | 10 | 2016 | 6426 | 0.400 |
Why?
|
Patient Admission | 2 | 2014 | 1367 | 0.320 |
Why?
|
Fee-for-Service Plans | 1 | 2013 | 700 | 0.290 |
Why?
|
Neuromuscular Diseases | 1 | 2010 | 258 | 0.280 |
Why?
|
Respiratory System | 1 | 2010 | 563 | 0.270 |
Why?
|
Child, Preschool | 16 | 2024 | 42232 | 0.260 |
Why?
|
Information Dissemination | 1 | 2014 | 1126 | 0.260 |
Why?
|
Congenital Abnormalities | 1 | 2010 | 709 | 0.240 |
Why?
|
Acute Disease | 1 | 2015 | 7237 | 0.230 |
Why?
|
Infant | 15 | 2024 | 36193 | 0.220 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2018 | 226 | 0.210 |
Why?
|
Continuous Positive Airway Pressure | 2 | 2024 | 575 | 0.210 |
Why?
|
Critical Care | 1 | 2015 | 2697 | 0.200 |
Why?
|
Health Care Surveys | 1 | 2009 | 2426 | 0.200 |
Why?
|
Asparaginase | 2 | 2015 | 240 | 0.190 |
Why?
|
Health Resources | 2 | 2009 | 935 | 0.180 |
Why?
|
Ventilators, Mechanical | 1 | 2002 | 288 | 0.170 |
Why?
|
Consensus | 1 | 2009 | 3124 | 0.160 |
Why?
|
Child | 14 | 2020 | 80158 | 0.150 |
Why?
|
Neoplasm, Residual | 2 | 2020 | 1008 | 0.150 |
Why?
|
Pediatrics | 1 | 2013 | 3589 | 0.150 |
Why?
|
Polyethylene Glycols | 2 | 2015 | 1189 | 0.140 |
Why?
|
Activities of Daily Living | 2 | 2016 | 2421 | 0.140 |
Why?
|
Long-Term Care | 2 | 2014 | 633 | 0.140 |
Why?
|
Infant, Newborn | 7 | 2024 | 26202 | 0.140 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2020 | 382 | 0.140 |
Why?
|
Respiratory Tract Diseases | 1 | 2002 | 750 | 0.130 |
Why?
|
Wheelchairs | 1 | 2016 | 78 | 0.130 |
Why?
|
Computer Simulation | 1 | 2010 | 6241 | 0.130 |
Why?
|
Male | 19 | 2024 | 360846 | 0.110 |
Why?
|
Hospitalization | 4 | 2020 | 10721 | 0.110 |
Why?
|
Sample Size | 1 | 2016 | 841 | 0.110 |
Why?
|
Female | 19 | 2024 | 392705 | 0.100 |
Why?
|
Movement Disorders | 1 | 2016 | 459 | 0.100 |
Why?
|
Mobility Limitation | 1 | 2016 | 408 | 0.100 |
Why?
|
Nervous System Diseases | 3 | 2016 | 1667 | 0.100 |
Why?
|
Massachusetts | 2 | 2015 | 8833 | 0.100 |
Why?
|
Retrospective Studies | 7 | 2024 | 80647 | 0.100 |
Why?
|
Humans | 25 | 2024 | 761596 | 0.090 |
Why?
|
Patient Care Planning | 1 | 2016 | 909 | 0.090 |
Why?
|
Treatment Outcome | 5 | 2024 | 64685 | 0.090 |
Why?
|
Aftercare | 1 | 2016 | 914 | 0.090 |
Why?
|
Oxygen | 1 | 2002 | 4227 | 0.090 |
Why?
|
Interpersonal Relations | 1 | 2016 | 1436 | 0.080 |
Why?
|
Hospital Costs | 1 | 2015 | 947 | 0.080 |
Why?
|
Causality | 1 | 2015 | 1242 | 0.080 |
Why?
|
Escherichia coli Proteins | 1 | 2015 | 1067 | 0.080 |
Why?
|
Tracheotomy | 1 | 2009 | 167 | 0.080 |
Why?
|
Chi-Square Distribution | 2 | 2013 | 3415 | 0.080 |
Why?
|
Multicenter Studies as Topic | 2 | 2018 | 1702 | 0.080 |
Why?
|
Program Evaluation | 1 | 2016 | 2495 | 0.070 |
Why?
|
Pulmonary Ventilation | 1 | 2010 | 372 | 0.070 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2015 | 1551 | 0.070 |
Why?
|
Respiratory System Abnormalities | 2 | 2009 | 67 | 0.070 |
Why?
|
Time Factors | 3 | 2017 | 39969 | 0.070 |
Why?
|
Recovery of Function | 1 | 2016 | 2979 | 0.070 |
Why?
|
Algorithms | 1 | 2006 | 14033 | 0.060 |
Why?
|
Clinical Trials, Phase III as Topic | 2 | 2020 | 857 | 0.060 |
Why?
|
Reproducibility of Results | 2 | 2016 | 20100 | 0.060 |
Why?
|
Mutation, Missense | 1 | 2014 | 2571 | 0.060 |
Why?
|
Masks | 1 | 2007 | 208 | 0.060 |
Why?
|
Self Care | 1 | 2010 | 796 | 0.060 |
Why?
|
Fractures, Bone | 1 | 2016 | 2046 | 0.060 |
Why?
|
Cohort Studies | 3 | 2017 | 41495 | 0.060 |
Why?
|
Analysis of Variance | 1 | 2013 | 6228 | 0.060 |
Why?
|
Adolescent | 8 | 2020 | 88326 | 0.050 |
Why?
|
Escherichia coli | 1 | 2015 | 4217 | 0.050 |
Why?
|
Tracheostomy | 1 | 2007 | 426 | 0.050 |
Why?
|
Cognition Disorders | 1 | 2016 | 3980 | 0.050 |
Why?
|
Infant, Premature, Diseases | 2 | 2009 | 710 | 0.050 |
Why?
|
Remission Induction | 2 | 2020 | 2397 | 0.040 |
Why?
|
Antineoplastic Agents | 2 | 2015 | 13642 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 11742 | 0.040 |
Why?
|
Intubation, Intratracheal | 1 | 2007 | 1333 | 0.040 |
Why?
|
Bronchopulmonary Dysplasia | 1 | 2003 | 326 | 0.040 |
Why?
|
Cognition | 1 | 2016 | 6992 | 0.040 |
Why?
|
Severity of Illness Index | 2 | 2007 | 15843 | 0.040 |
Why?
|
Prognosis | 2 | 2020 | 29629 | 0.040 |
Why?
|
Epilepsy | 1 | 2014 | 3290 | 0.040 |
Why?
|
Inpatients | 1 | 2010 | 2548 | 0.040 |
Why?
|
Chronic Disease | 3 | 2009 | 9319 | 0.040 |
Why?
|
Intensive Care Units, Pediatric | 1 | 2004 | 1017 | 0.040 |
Why?
|
Ikaros Transcription Factor | 1 | 2018 | 232 | 0.030 |
Why?
|
Risk Assessment | 1 | 2018 | 23996 | 0.030 |
Why?
|
Incidence | 1 | 2015 | 21355 | 0.030 |
Why?
|
Pilot Projects | 1 | 2010 | 8633 | 0.030 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2018 | 305 | 0.030 |
Why?
|
Developmental Disabilities | 1 | 2004 | 1509 | 0.030 |
Why?
|
Neurons | 1 | 2014 | 9463 | 0.030 |
Why?
|
Intention to Treat Analysis | 1 | 2015 | 413 | 0.030 |
Why?
|
Injections, Intramuscular | 1 | 2015 | 554 | 0.030 |
Why?
|
Leukocyte Count | 1 | 2018 | 1596 | 0.030 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2018 | 682 | 0.030 |
Why?
|
Young Adult | 2 | 2020 | 59260 | 0.030 |
Why?
|
Prospective Studies | 2 | 2007 | 54423 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2020 | 10212 | 0.030 |
Why?
|
Patch-Clamp Techniques | 1 | 2014 | 927 | 0.020 |
Why?
|
Survival Rate | 2 | 2020 | 12723 | 0.020 |
Why?
|
Pyramidal Cells | 1 | 2014 | 369 | 0.020 |
Why?
|
United States | 3 | 2015 | 72340 | 0.020 |
Why?
|
Multivariate Analysis | 2 | 2018 | 12059 | 0.020 |
Why?
|
Membrane Potentials | 1 | 2014 | 1090 | 0.020 |
Why?
|
Canada | 1 | 2015 | 2122 | 0.020 |
Why?
|
Age Factors | 2 | 2018 | 18399 | 0.020 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2014 | 2748 | 0.020 |
Why?
|
Logistic Models | 1 | 2003 | 13255 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2020 | 3639 | 0.020 |
Why?
|
Utilization Review | 1 | 2009 | 382 | 0.020 |
Why?
|
Age of Onset | 1 | 2014 | 3306 | 0.020 |
Why?
|
Action Potentials | 1 | 2014 | 1834 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2003 | 15266 | 0.020 |
Why?
|
Transfection | 1 | 2014 | 5774 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2014 | 4111 | 0.020 |
Why?
|
Survival Analysis | 1 | 2018 | 10090 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2015 | 6815 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2015 | 6484 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 2009 | 2217 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2014 | 4281 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2020 | 39106 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2014 | 8181 | 0.010 |
Why?
|
Hippocampus | 1 | 2014 | 3766 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2015 | 12463 | 0.010 |
Why?
|
Boston | 2 | 2004 | 9327 | 0.010 |
Why?
|
Risk Factors | 2 | 2018 | 74213 | 0.010 |
Why?
|
Lung Diseases | 1 | 2009 | 1909 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2009 | 5247 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2004 | 2850 | 0.010 |
Why?
|
Rats | 1 | 2014 | 23741 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2009 | 5293 | 0.010 |
Why?
|
Patient Transfer | 1 | 2002 | 794 | 0.010 |
Why?
|
Comorbidity | 1 | 2009 | 10508 | 0.010 |
Why?
|
Quality of Life | 1 | 2015 | 13367 | 0.010 |
Why?
|
Critical Illness | 1 | 2004 | 2723 | 0.010 |
Why?
|
Adult | 1 | 2020 | 221210 | 0.000 |
Why?
|
Animals | 1 | 2014 | 168475 | 0.000 |
Why?
|
Concepts
(152)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(16)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_